Ediz Tasan, MD
Cardiovascular Disease · Pascagoula, MSNPI 1053670166
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $25,465 of the $41,880 with a category attached, or 60.8%. It is spread thinly across 50 manufacturers, the largest accounting for just 21.2%. Among cardiovascular disease clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 862 payments — averaging $48.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$9K
- Medtronic$8K
- Boston Scientific$5K
- Abbott$4K
- Bard Peripheral Vascular, Inc.$2K
- Abiomed$2K
- plus $12K from 44 others
What the payments were for
- Consulting fees$1,5004%
- Travel & lodging$6,14715%
- Food & beverage$25,46561%
- Education$1210%
- Gifts$750%
- Other$8,57120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$8,474
- Mitra Clip system$1,939
- NRG needle$1,112
- Watchman$1,098
- Micra$1,049
- FLOWTRIEVER CATHETER, S$881
- CoreValve Evolut$674
- CT THROMBECTOMY SYSTEM KIT$647
- Impella$591
- AVVIGO Guidance System$487
- COREVALVE EVOLUT R$424
- SYMPHONY CATHETER$392
- AlphaVac$389
- WATCHMAN Access System$357
- Torus Stent Graft System$309
- ENDOCROSS Device$309
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$271
- GENERAL - STRUCTURAL HEART$267
- VENOVO$247
- JARDIANCE$232
How this compares
$41,880 in reported general payments places this provider in the 95th percentile of 144 cardiovascular disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 266 | $202,505 |
| EntrestoSacubitril/Valsartan | 107 | $98,279 |
| XareltoRivaroxaban | 70 | $82,615 |
| Repatha SureclickEvolocumab | 34 | $22,883 |
| JardianceEmpagliflozin | 16 | $13,641 |
| BrilintaTicagrelor | 23 | $12,527 |
| Ranolazine ErRanolazine | 45 | $3,304 |
| Nebivolol Hcl | 58 | $2,957 |
| Potassium Chloride | 83 | $2,694 |
| ClopidogrelClopidogrel Bisulfate | 274 | $2,625 |
| Metoprolol Succinate | 180 | $2,238 |
| Atorvastatin Calcium | 270 | $1,737 |
| Midodrine Hcl | 23 | $1,722 |
| Carvedilol | 250 | $1,404 |
| Furosemide | 325 | $1,366 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $405 | $202,505266 claims |
| NovartisEntresto | $566 | $98,279107 claims |
| Johnson & JohnsonXarelto | $402 | $82,61570 claims |
| Boehringer IngelheimJardiance | $347 | $13,64116 claims |
| AstraZenecaBrilinta | $234 | $12,52723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 144 cardiovascular disease providers in Mississippi.
Other cardiovascular disease in Pascagoula
- Mahmoud ZayedPascagoula$103K
- Hugo QuintanaPascagoula$48K
- Simon RizkPascagoula$16K
- William PassarelliPascagoula$15K
- Dharmesh PatelSouthaven$1.5M
- Barry BertoletTupelo$469K
- Donny StokesJackson$207K
- James BenslerJackson$64K
- Michael HallJackson$54K
- Lawrence LeaderHattiesburg$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.